PECULIARITIES OF PSYCHOCORRECTION AND PSYCHOPROPHYLACTICS OF MAIN FORMS IN ANXIETY DISORDERS

Full Text

Abstract

There were discussed results of psychocorrective and psychiprophilactic measures with consideration of typism and atypism of clinical manifestations as exemplified of 204 cases of generalized anxiety disorder (GAD) and 189 cases of panic disorder (PD).

Full Text

ОСОБЕННОСТИ ПСИХОКОРРЕКЦИИ И ПСИХОПРОФИЛАКТИКИ ОСНОВНЫХ ФОРМ ТРЕВОЖНЫХ РАССТРОЙСТВ
×

About the authors

Vladimir M Yaltonsky

Moscow state medical and stomatologic university

Email: yaltonsky@mail.ru
127473,Моscow,Delegatsky street, 20, building.1

Aleksei A Atamanov

South-Ural state medical university

Email: atamanov_psy@mail.ru
454091, Chelyabinsk,Vorovsky street, 64

References

  1. Менделевич В.Д. О некоторых психологических механизмах неврозогенеза // Психологический журнал. 1990. №6. С.113‒117
  2. Менделевич В.Д. Расстройства зависимого поведения (к постановке проблемы) // Российский психиатрический журнал. 2003. №1. С. 5‒9
  3. Старшенбаум А.В. Суицидология и кризисная психотерапия. М.: Когито-центр, 2005. 376 с
  4. Цыганков Д.Б., Малыгин В.Л., Агасарян Э.Г., Цыганков Б.Д. Психологические защиты у больных алкоголизмом и паническим расстройством // Журнал неврологии и психиатрии им. С.С. Корсакова. 2008. Т. 108, №11. С. 96–97
  5. Boden J.M., Fergusson D.M., Horwood L.J. Anxiety disorders and suicidal behaviors in adolescence and young adulthood: findings from a longitudinal study // Psychol. Med. 2007. Vol. 37. P. 431–440
  6. Davidson J.R., Wittchen H.U., Llorca P.M. et al. Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo controlled trial // Eur. Neuropsychopharmacol. 2008. Vol. 18. P. 673–681
  7. Grant B.F., Hasin D.S., Stinson F.S. et al. Prevalence, correlates, comorbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the national epidemiologic survey on alcohol and related conditions // Psychol. Med. 2005. Vol. 35. P. 747–759
  8. Kessler R.C., Berglund P., Demler O. et al. Lifetime prevalence and age of onset distributions of DSM-IV disorders in the national comorbidity survey replication // Arch. Gen. Psychiatry. 2005. Vol. 62. P. 593–602
  9. Lorenz R.A., Jackson C.W., Saitz M. Adjunctive Use of Atypical Antipsychotics for Treatment-resistant Generalized Anxiety Disorder // Pharmacotherapy. 2010. Vol. 30(9). P. 942‒951
  10. Menza M.A., Dobkin R.D., Marin H. An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder // J. Clin. Psychopharmacol. 2007. Vol. 27. P. 207–210
  11. Wittchen H.U. Generalized anxiety disorder: prevalence, burden, and cost to society // Depress Anxiety 2002. Vol. 16. P. 162–171

Statistics

Views

Abstract: 126

Dimensions

Article Metrics

Metrics Loading ...

PlumX

Refbacks

  • There are currently no refbacks.

Copyright (c) 2013 Yaltonsky V.M., Atamanov A.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies